Home Tags TSX:CRDL

Tag: TSX:CRDL

Cannabis

Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx(TM), into...

Cannabis

Cardiol Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare...

Cannabis

Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants Issued on...

Cannabis

Cardiol Therapeutics Appoints Michael J. Willner to Its Board of Directors

Cannabis

Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application...

Cannabis

Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”

Cannabis

Cardiol Therapeutics’ Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman

Cannabis

Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting

Cannabis

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on...

Cannabis

Cardiol Therapeutics Closes $22 Million Bought Deal Offering

1234Page 1 of 4
GrassNews digests/handpicks the latest news about the legal cannabis and CBD industries and serves them to you daily. We provide you with the latest news and press releases straight from the heart of the industry.
Contact us: hello@picante.today

PICANTE Media and Events (part of Hipther Agency) is a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports.

Contact us: sales@picante.today

>Editorial / PR Submissions

Copyright © 2018 - 2021 PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania